IpiNovyx Bio
Developing multiple series of highly selective, ultra potent small molecule therapeutics for the treatment of autoimmune and inflammatory disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD62—93m (Dealroom.co estimates Oct 2021.)
Town of Clarkstown New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $10.0m | Seed | |
| Total Funding | AUD15.5m | ||